House too hot? Energy bill already too high? This UK professor says smearing yogurt on your windows can cool your home
The summer of 2025 is already a scorcher—and we've got a long way to go. It's not just the U.S., either. The UK is experiencing a massive heatwave that has resulted in health alerts across parts of the country. That's especially problematic as few homes in that country have air conditioning—and it's resulting in some rather unique solutions.
A professor at Loughborough University has come up with an especially odd way to cool your home that is a lot more effective than you might imagine: Smear some yogurt on the window.
Dr. Ben Roberts says putting yogurt on the outside of windows can lower the temperature by up to 6.3 degrees (Farenheit). The numbers come following a one-month experiment, where two identical test houses braved the heat—one with yogurt windows, one without.
On average, the yogurt house was one degree (F) cooler, but it saw a difference of 6.3 degrees on 'hot and sunny' days. The yogurt results in a film on the windows, which blocks some of the solar radiation, which raises the temperature.
(If you're thinking of trying to recreate this, Roberts says they used Greek yogurt with a fat percentage of about 10%. He didn't add, but it seems logical to add that you'll want to skip the fruit-flavored varieties when doing so.)
Roberts admits he was 'quite surprised' when he saw the temperature differences, adding he didn't think the diary product would be as effective as it was in blocking heat.
Worried about the smell? Roberts says that faded as soon as the yogurt had dried, which took less than a minute. He did not, however, address whether the application of yogurt on the windows attracted more bugs.
This story was originally featured on Fortune.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Da Vinci's Vitruvian Man Encodes the Blueprint of Human Evolution, Says London Dentist
New research reveals a hidden geometric ratio in Leonardo's drawing that may define the endpoint of human evolution toward upright posturePhoto Courtesy of Rory Mac Sweeney LONDON, July 14, 2025 (GLOBE NEWSWIRE) -- A London-based dental surgeon and researcher, Dr. Rory Mac Sweeney of Precision Endodontics, has ignited international interest with a provocative reinterpretation of Leonardo da Vinci's Vitruvian Man. His newly published research suggests the Renaissance masterpiece encodes a precise geometric ratio that reflects the biomechanical endpoint of human evolution. Dr. Mac Sweeney's theory, published in the Journal of Mathematics and the Arts, identifies a hidden equilateral triangle embedded in Vitruvian Man. He connects this geometry to Bonwill's Triangle—a fundamental dental structure first described in the 19th century, which governs optimal jaw alignment and function. According to Mac Sweeney, this triangular structure appears throughout the body and is mathematically anchored by the ratio √8/3, or approximately 1.633. 'Leonardo's drawing isn't just a study in proportion—it's a map of tension,' said Dr. Mac Sweeney. 'The 1.633 ratio appears in the jaw, the spine, and the skull. It reflects a state known as vector equilibrium, where structural tension and compression are perfectly balanced. I believe this marks the final step in the human journey toward full upright posture.' This ratio, derived from the geometry of the cuboctahedron, is widely recognized in biomechanics and architecture as a hallmark of tensegrity—the balance of forces within a stable form. Dr. Mac Sweeney contends that this geometry defines the Vitruvian Morphotype: a form that nature has converged on through evolutionary pressures—not because it is aesthetically pleasing, but because it is structurally optimal. 'Human evolution has been a long progression toward uprightness,' he explained. 'The 1.633 ratio may represent our evolutionary omega point—a structural threshold beyond which no further anatomical adaptation is needed to stand, move, and balance efficiently in gravity.' Mac Sweeney suggests that fossil evidence should reveal a slow convergence toward this geometric configuration, particularly in the jaw. He highlights the emergence of Class I occlusion in the fossil record—also known as the overbite/overjet 'step'—around 8,000 years ago as a key moment. While small variations remain, he argues that modern Homo sapiens are the first species to fully express this morphotype. 'It's like the hydrodynamic form of a dolphin,' he said. 'Nature solves gravity the way it solves water. Vitruvian Man is the first full sketch of what that solution looks like.' Dr. Mac Sweeney's theory is now attracting attention from experts in evolutionary biology, bioengineering, and anatomical design. He is currently conducting interviews, public talks, and media appearances to discuss what he calls the Vitruvian Ratio—and its broader implications for anthropology, architecture, and even consciousness. 'Leonardo, somehow, saw it coming,' Mac Sweeney added. 'Vitruvian Man may be the only anatomical diagram ever created that captures not just what a human is—but what a human is becoming.' About Dr. Rory Mac Sweeney: Dr. Mac Sweeney is a London-based endodontist and researcher known for his interdisciplinary work in dental anatomy, geometry, and human evolution. His work explores the convergence of structural biology and classical design, and he is the author of the book The Paradox of Lucid Dreaming. @luciddreamyoga Contact Information: Contact person: Dr. Rory Mac SweeneyCompany name: Precision EndodonticsWebsite: [ Contact: rorymacsweeney@ A photo accompanying this announcement is available at in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
UK children taken to hospital after using vapes laced with Spice
An increase in vapes contaminated with synthetic drug Spice has led to secondary school children being rushed to hospital. The lab-made drug which mimics the effects of cannabis but with much stronger consequences, can cause breathing problems, heart attacks and seizures. Other symptoms include feeling dizzy, vomiting, heart racing, sweating, anxiety, and paranoia. Police have warned of a national increase in vapes being contaminated with spice in secondary schools and in severe cases children have been taken to hospital. It comes after a study in a university-led study last year heard from headteachers who reported children collapsing and ending up in hospital. 'We've seen vomiting and behaviour changes, and we've had an incident where there were concerns that a child was having a fit. The reactions can be very, very broad,' PSCO Jon Akehurst from Wiltshire Police warned. Police warn of an national increase in vapes laced with Spice (Alamy/PA) Working with Bath University, Swindon Borough Council and Wiltshire Council, police are using a new device to test any suspected contaminated vapes to prevent any further harm to students. "I'd urge parents to have conversations with your child about the dangers and risks as well as what happens if they do use a vape which is contaminated with something,' PCSO Akehurst said. "Make it clear that if you do take these things, it has an impact on your life,' he added. Officers are urging parents to talk to their children about the dangers of using contaminated vapes from the health effects to the impact it can have on your life. PCOS Akehurst warned that there can be many different reactions to the lab-made drug. "You may have a substance addiction; you might need it constantly, it's going to cost you money, and you could end up in debt. There are real-life consequences for anyone taking drugs. If you are concerned about your child, there are people that can help and support you,' he said. Cannabis substitute Spice can cause breathing problems, heart attacks and seizures (Creative Commons) The stark warning comes after an investigation by the University of Bath found one in six vapes confiscated from schools contained Spice. The study published in July last year saw vapes confiscated in 38 schools in England, finding more than 16 per cent contained the synthetic form of cannabis. Professor Chris Pudney, from the university's department of life sciences, conducted the tests using the device that instantly detects synthetic drugs. Professor Pudney said: "We know children can have cardiac arrests when they smoke spice, and I believe some have come quite close to death. 'Headteachers are telling me pupils are collapsing in the halls and ending up with long stays in intensive care.'
Yahoo
an hour ago
- Yahoo
Less aggressive treatment for low-risk breast cancer ‘just as effective'
More targeted and less aggressive radiotherapy for low-risk breast cancer could spare thousands of women from the harsh side-effects of the treatment, a trial has found. The technique, which has since been adopted by the NHS, has 'transformed' the way the disease is treated in its early stages, researchers said. More than 37,000 women have radiotherapy for breast cancer in the UK every year. The treatment uses radiation to kill cancer cells and is usually given after surgery to reduce the risk of the disease coming back. However, side-effects can include changes in breast size and shape, swelling in the arms or breast, and pain. The Import Low trial, led by The Institute of Cancer Research, London, and the University of Cambridge, found limiting radiation to the tumour area, rather than treating the whole breast, was just as effective. The study included 2,018 women across 30 radiotherapy centres in the UK, who were monitored for 10 years after treatment. It compared three radiotherapy approaches; whole-breast, partial-breast and a reduced-dose. After a decade, cancer recurrence rates in the group given partial radiotherapy was 3%, the same proportion as those who had been treated with a more aggressive approach. Patients who had targeted radiotherapy were also less likely to experience long-term changes in breast appearance. Some 15% reported noticeable changes at five years compared with 27% in the whole-breast radiotherapy group. Dr Anna Kirby, consultant clinical oncologist at The Royal Marsden NHS Foundation Trust, and reader in breast cancer radiotherapy at The Institute of Cancer Research, London, said: 'The long-term results of this study confirm that a less aggressive approach, limiting radiotherapy to the tumour rather than the whole breast, is just as effective as traditional whole-breast radiotherapy. 'Patients receiving partial-breast radiotherapy experience fewer side-effects while maintaining excellent cancer control.' Charlotte Coles, a professor of breast cancer clinical oncology at the University of Cambridge, honorary clinical oncology consultant at Cambridge University Hospitals NHS Foundation Trust, and chief investigator of the Import Low study, said the trial has 'transformed' how early breast cancer is treated. Following the study, which is published in the Lancet Oncology, partial-breast radiotherapy has been integrated into NHS treatment guidelines. It is hoped that more than 9,000 women in the UK could benefit from more targeted treatment. 'By targeting the area around the tumour, rather than the whole breast, we have demonstrated that patients can achieve the same outstanding long-term outcomes with fewer complications,' Prof Coles said. 'This approach is now widely adopted across the NHS, sparing thousands of women from unnecessary radiation exposure. 'The results of this study have not only shaped UK clinical practice but also informed international guidelines, ensuring that women worldwide benefit from this personalised, evidence-based treatment.' Hilary Stobart, now 70, was diagnosed with ER-positive breast cancer in December 2008, with a 2cm tumour in her left breast. Ms Stobart, who was 54 at the time, was offered the chance to take part in the trial after surgery and was treated with partial radiotherapy. 'I had three weeks of radiotherapy, but suffered no side-effects, other than some soreness in my breast and nipple in the first few weeks,' she said. 'Ten years on, I am doing fine. I have no side-effects and no recurrence of disease. 'For me personally, I am very thankful to have received the lowest dose of radiotherapy. 'Whilst I may have had some niggling worries in the early days, having seen the results of the trial, I feel positive and optimistic now. I know that I was lucky enough back then to have had the best treatment, a treatment that other women will be routinely offered now.' Dr Fay Cafferty, lead statistician at The Institute of Cancer Research, London, added that the findings are 'crucial in reinforcing the long-term safety and effectiveness of partial-breast radiotherapy'. 'Long-term data is vital to ensure we know there's no greater risk of breast cancer returning after this targeted radiotherapy treatment,' she said. 'This latest analysis confirms that partial breast radiotherapy remains a safe and effective treatment option, supporting its continued adoption as the standard of care in the UK and globally.'
